Evidence map›Paper›PMID 42779537›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2026

Lipoprotein(a) and Incident Aortic Stenosis Over 30 Years: The ARIC Study.

Rafael Zubirán, Anna Wolska, Alan T Remaley

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rafael ZubiránLipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD (R.Z., A.W., A.T.R.).ORCID 0000-0003-4274-3585
Anna WolskaLipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD (R.Z., A.W., A.T.R.).ORCID 0000-0001-9479-0741
Alan T RemaleyLipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD (R.Z., A.W., A.T.R.).ORCID 0000-0003-2473-5549

Funding

Development and assessment of cardiovascular risk biomarkersZIAHL006275 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI REMALEY, ALAN THOMAS · 2022 to 2025
$6.0M
Intramural NIH HHS Z99 HL999999Intramural NIH HHS ZIA HL006275
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

aortic valve stenosisBlack or African Americanhospitalizationimmunoassaylipoprotein(a)prospective studiesrisk factors

Identifiers

PMID42779537
PMCPMC13614517

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.